Navigation Links
Schering-Plough Reports Financial Results for Third Quarter of 2008
Date:10/21/2008

Net Income $589 $750 $1,315 $1,853

==== ==== ====== ======

Preferred stock

dividends 38 37 113 80

-- -- --- --

Net income available

to common

shareholders $551 $713 $1,202 $1,773

==== ==== ====== ======

Diluted Earnings per

common share

$0.34 $0.45 $0.74 $1.15

===== ===== ===== =====

Average shares outstanding

- diluted 1,636 1,622 1,635 1,596

The company incurs substantial costs related to the cholesterol joint

venture, such as selling, general and administrative costs, that are not

reflected in the "Equity income" and are borne by the overall cost

structure of Schering-Plough.

1/ Net sales for the three and nine months ended September 30, 2008,

include sales of $1.4 billion and $4.2 billion, respectively, from Organon

BioSciences (OBS) which was acquired on November 19, 2007.

2/ Cost of sales for the three and nine months ended September 30, 2008

include purchase accounting adjustments of $221 million and $1.3 billion,

respectively, related to the acquisition of OBS.

3/ Research and development for the three and nine months ended September

30, 2007 include $20 million and $176 million, respectively, related to

upfront R&D payments.

4/ Included in other expense/(income), net for the three and nine months

ended September 30, 2008 were $160 million related to the previously

announced divestiture of certain animal health products. Included in other

expense/(income), net for the three and nine months e
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. Schering-Plough Announces Transition of Animal Health Leadership
2. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
3. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
4. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
5. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
6. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
7. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
9. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
10. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... May 18, 2013 MOOSGO.COM published an original ... This book features a group of artists who share their ... photographs, illustrations and paintings. Exclusively for iPad . ... including songs and videos that reflect the signature idiosyncrasy and ... at the Apple iBook Store and it includes a ...
(Date:5/18/2013)... Minn. -- Regular consumption of coffee is associated ... (PSC), an autoimmune liver disease, Mayo Clinic research ... Digestive Disease Week 2013 conference in Orlando, Fla. ... the bile ducts that results in inflammation and ... the liver, liver failure and biliary cancer. , ...
(Date:5/18/2013)... ground-breaking advance in colonoscopy technology signals the future ... at Digestive Disease Week (DDW). Additional research focuses ... and exploring safer methods for removing polyps. ... called a colonoscope to examine the colon. This ... to look for precancerous polyps called adenomas in ...
(Date:5/18/2013)... Coral Springs, FL (PRWEB) May 18, 2013 ... segment dedicated to the special places we call home. These ... found on maps. They are the locations where the people ... The first-rate show takes viewers off the highways and shares ... the best of both nations with an American sports and ...
(Date:5/18/2013)... May 18, 2013 After working diligently for ... SizeItUp formally announced the integration of the fitment specs ... Genesis is set to stun the automobile market with its ... Hyundai Genesis is marked as the latest entry in the ... vehicles lined up for the year 2013. , Aptly ...
Breaking Medicine News(10 mins):Health News:New Art Book for iPad: Tango Art 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2
... continue volunteer relief project for one more month ... On Disaster,Response (HODR), a volunteer-driven 501(c) 3 nonprofit ... volunteer,project in Rayenda, Bangladesh to help those devastated ... Bangladesh in over 15 years, hit the,coastline November ...
... issues of transgender identities -- in the workplace and professional ... vocational counselors to not only treat but to act as ... in the workplace. , "One of the main points of ... be, as vocational psychologists or career counselors, working with transgender ...
... Choices ( http://www.nhs.uk ), the,digital ,front door, to ... aimed to,help people improve their fitness levels., ... http://www.nhs.uk/Livewell/fitness/Pages/fitnesshome.aspx ) enables users,to get the low down ... and,provides them with clinically approved guidance to help ...
... social cues may mimic those of people, scientists say ... have social lives, too, and watching how their brains ... social behavior and autism. , Little is known about ... it to manage behavior, notes a team of researchers ...
... 2008 In workplaces where nurses are bullied, the ... suffers, and the retention of quality nurses becomes difficult. ... Gynecologic, & Neonatal Nursing reviews the psychological and social ... for creating a respectful work environment. , More ...
... of World TB Day 2008 (March 24), the Infectious ... Association (HIVMA) are urging U.S. policymakers to step up ... the disease both at home and abroad. , With ... in detecting new cases on the decline, resources are ...
Cached Medicine News:Health News:Hands on Disaster Response Extends Cyclone Relief Project 2Health News:Counselors should target discrimination and be advocates for transgender clients 2Health News:Counselors should target discrimination and be advocates for transgender clients 3Health News:Monkey Brain Gives Clues to Human Interaction 2Health News:ID, HIV experts urge more resources for TB 2
(Date:5/17/2013)... 17, 2013 Oramed Pharmaceuticals Inc. ... drug delivery systems, announced today that the United States ... Investigational New Drug application(IND) for ORMD-0801, its oral insulin ... the FDA clearance to proceed," stated Nadav ... is a major milestone for Oramed and we look ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)...  Nektar Therapeutics, (Nasdaq: NKTR ) President and ... is scheduled to present at the upcoming 2013 UBS Global ... the Sheraton New York Hotel on Tuesday, May 21, 2013 ... be accessible via a Webcast through a link posted in ... http://www.nektar.com . This Webcast will be available for replay ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... The E-Holder™ Platform is designed with ... E-Gel® 96 and E-Gel® 48 gel cassettes ... This allows reproducible placement and loading from ... to make adjustments to the robot loading ...
... electrophoresis into an automated, high-throughput operation with ... system is ideal for analyzing multiple PCR ... Fully automated, robot-compatible, and ready to put ... your high-throughput screening assignments as easy as ...
... the possibility of leakage around glued or bonded ... gel trays meaning you do no have to ... friendliness, the Primo tanks come with built-in leveling ... Gel Systems are designed to be durable and ...
... formed directly on the UV-transparent gel bed using ... it cools, or outside the unit using a ... 7.5cm wide 10cm long. Different colors are offered ... only). Combs and tape are not included. Gel ...
Medicine Products: